McCann Corey 4

4 · Pear Therapeutics, Inc. · Filed Feb 18, 2022

Form 4

Period: 2022-02-16

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2022-02-16+210,080→ 210,080 total
Exercise: $4.06Exp: 2032-02-16→ Common Stock (210,080 underlying)
Award
Restricted Stock Units
2022-02-16+266,667→ 266,667 total
→ Common Stock (266,667 underlying)

Holdings

Footnotes (7)

[F1]Updated to correct error in prior Form 4 filing.
[F2]The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
[F3]Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
[F4]Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
[F5]25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter.
[F6]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
[F7]The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.

Documents

1 file